tupungato
Tevogen Bio (NASDAQ:TVGN) shares jumped nearly 30% after the company announced it had expanded its relationship with Microsoft (NASDAQ:MSFT) to expand their AI-focused collaboration and build their PredicTcell technology for predictive precision targeting of T cells.
The Tevogen.AI initiative will